Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases

Antioxidants and Redox Signaling

Volumn 19, Issue 10, 2013, Pages 1074-1084

  Chan, Samuel H H ^a   Chan, Julie Y H ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADENOVIRUS VECTOR; ANGIOTENSIN; ARYLDIALKYLPHOSPHATASE; CYTOCHROME P450 REDUCTASE; GLUTAREDOXIN; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXYGENASE; LOSARTAN; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PEROXIREDOXIN; PROTEIN KINASE C; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; THIOREDOXIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; XANTHINE OXIDASE;

BLOOD BRAIN BARRIER; BRAIN; BRAIN MICROCIRCULATION; BRAIN REGION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; DNA BINDING; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FEEDBACK SYSTEM; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MITOCHONDRION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRESSOR RESPONSE; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SOLITARY TRACT NUCLEUS; SYMPATHETIC TONE;

ANGIOTENSIN II; ANIMALS; BRAIN; CARDIOVASCULAR DISEASES; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84884198668     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4585     Document Type: Review

References (108)

1. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, and Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26: 435-439, 2000.
2. Basset O, Deffert C, Foti M, Bedard K, Jaquet V, Ogier- Denis E, and Krause KH. NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle. Antioxid Redox Signal 11: 2371-2384, 2009.
3. Bruckdorfer KR. Antioxidants and CVD. Proc Nutr Soc 67: 214-222, 2008.
4. Burger D, Montezano AC, Nishigaki N, He Y, Carter A, and Touyz RM. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/ NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 31: 1898-1907, 2011.
5. Campese VM, Shaohua Y, and Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46: 533-539, 2005.
6. Chan SHH, Hsu KS, Huang CC, Wang LL, Ou CC, and Chan JYH. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 97: 772-780, 2005.
7. Chan SHH, Tai MH, Li CY, and Chan JYH. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med 40: 2028-2039, 2006.
8. Chan SHH, Wang LL, Tseng HL, and Chan JYH. Upregulation of AT1 receptor gene on activation of protein kinase C b/nicotinamide adenine dinucleotide diphosphate oxidase/ ERK1/2/c-fos signalling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens 25: 1845-1861, 2007.
9. Chan SHH, Wu CA, Wu KLH, Ho YH, Chang AYW, and Chan JYH. Transcriptional upregulation of uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res 105: 886-896, 2009.
10. Chan SHH, Wu CWJ, Chang AYW, Hsu KS, and Chan JYH. Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure. Circ Res 107: 1127-1139, 2010.
11. Chan SHH, Wu KLH, Chang AYW, Tai MH, and Chan JYH. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 53: 217-227, 2009.
12. Chan SHH, Wu KLH, Kung PSS, and Chan JYH. Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-c and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension 55: 1444-1453, 2010.
13. Chandel NS and Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 88: 1880-1889, 2000.
14. Chen QH, Andrade MA, Calderon AS, and Toney GM. Hypertension induced by angiotensin II and a high salt diet involves reduced SK current and increased excitability of RVLM projecting PVN neurons. J Neurophysiol 104: 2329- 2337, 2010.
15. Costantini LC, Bakowska JC, Breakefield XO, and Isacson O. Gene therapy in the CNS. Gene Ther 7: 93-109, 2000.
16. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 285: R498-R511, 2003.
17. Descamps D and Benihoud K. Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction. Curr Gene Ther 9: 115-127, 2009.
18. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, and Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
19. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78: 583-686, 1998.
20. Gao L, Li Y, Schultz HD, Wang WZ, Wang W, Finch M, Smith LM, and Zucker IH. Downregulation of Kv4.3 expression in RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 298: H945-H955, 2010.
21. Gao L, Wang W, and Zucker IH. Simvastatin inhibits central sympathetic outflow in heart failure by a nitric-oxide synthase mechanism. J Pharmacol Exp Ther 326: 278-285, 2008.
22. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, and Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944, 2004.
23. Gao L, Wang W, Li YL, Schultz HD, Liu DM, Cornish KG, and Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
24. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, and Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580: 497-504, 2006.
25. Gilmore JL, Yi X, Quan L, and Kabanov AV. Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 3: 83-94, 2008.
26. Girouard H, Park L, Anrather J, Zhou P, and Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arterioscler Thromb Vasc Biol 26: 826-832, 2006.
27. Glass MJ, Chan J, Frys KA, Oselkin M, Tarsitano MJ, Iadecola C, and Pickel VM. Changes in the subcellular distribution of NADPH oxidase subunit p47phox in dendrites of rat dorsomedial nucleus tractus solitarius neurons in response to chronic administration of hypertensive agents. Exp Neurol 205: 383-395, 2007.
28. Gregg D, Rauscher FM, and Goldschmidt-Clermont PJ. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol 285: C723-C734, 2003.
29. Griendling KK, Sorescu D, Lassègue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
30. Han Y, Yuan N, Zhang SJ, Gao J, Shi Z, Zhou YB, Gao XY, and Zhu GQ. c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats. Pflugers Arch 461: 437-446, 2011.
31. Hirooka Y. Adenovirus-mediated gene transfer into the brain stem to examine cardiovascular function: role of nitric oxide and Rho-kinase. Prog Biophys Mol Biol 84: 233-249, 2004.
32. Hongpaisan J, Winters CA, and Andrews SB. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci 24: 10878-10887, 2004.
33. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, and Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarctioninduced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774, 2010.
34. Infanger DW, Sharma RV, and Davisson RL. NADPH oxidases of the brain: distribution, regulation and function. Antioxid Redox Signal 8: 1583-1596, 2006.
35. Jackman KA, Miller AA, Drummond GR, and Sobey CG. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain Res 1286: 215-220, 2009.
36. Ji Y, Liu J, Wang Z, and Liu N. Angiotensin II induces inflammatory response partly via toll-like receptor 4- dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 23: 265-276, 2009.
37. Joglar B, Rodriguez-Pallares J, Rodríguez-Perez AI, Rey P, Guerra MJ, and Labandeira-Garcia JL. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem 109: 656-669, 2009.
38. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, and Francis J. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin IIinduced hypertension. Cardiovasc Res 82: 503-512, 2009.
39. Kang YM, Zhang ZH, Xue B, Weiss RM, and Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemiainduced heart failure. Am J Physiol Heart Circ Physiol 295: H227-H236, 2008.
40. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, and Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95: 1019-1026, 2004.
41. Kimura S, Zhang GX, and Abe Y. Malfunction of vascular control in lifestyle-related diseases: oxidative stress of angiotensin II-induced hypertension: mitogen-activated protein kinases and blood pressure regulation. J Pharmacol Sci 96: 406-410, 2004.
42. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109: 2357-2362, 2004.
43. Kishi T, Hirooka Y, Konno S, Ogawa K, and Sunagawa K. Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signalregulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 55: 291-297, 2010.
44. Lambert AJ and Brand MD. Inhibitors of the quinonebinding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 279: 39414-39420, 2004.
45. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
46. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511-515, 2002.
47. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1366: 53-67, 1998.
48. Liu D, Gao L, Roy SK, Cornish KG, and Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004-1011, 2006.
49. Liu D, Gao L, Roy SK, Cornish KG, and Zucker IH. Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193, 2008.
50. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677-2685, 2005.
51. Mayorov DN. Brain superoxide as a key regulator of the cardiovascular response to emotional stress in rabbits. Exp Physiol 92: 471-479, 2007.
52. Mayorov DN, Head GA, and Matteo R. Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress. Hypertension 44: 101-106, 2004.
53. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, and Young IS. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT); a randomized placebo-controlled trial. Lancet 376: 259-266, 2010.
54. Miller AA, Drummond GR, and Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 111: 928-948, 2006.
55. Mitra AK, Gao L, and Zucker IH. Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons. Am J Physiol Cell Physiol 299: C561-C569, 2010.
56. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, and Touyz RM. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 28: 1511-1518, 2008.
57. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD, and Eguchi S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 4: 67-78, 2006.
58. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, and Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens 26: 2176-2184, 2008.
59. Okado-Matsumoto A and Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn- SOD in mitochondria. J Biol Chem 276: 38388-38393, 2001.
60. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, and Campos RR. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22: 484-492, 2009.
61. Osborn JW, Fink GD, Sved AF, Toney GM, and Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
62. Pan YX, Gao L, Wang WZ, Zheng H, Liu D, Patel KP, Zucker IH, and Wang W. Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension 49: 519-527, 2007.
63. Park L, Anrather J, Girouard H, Zhou P, and Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab 27: 1908-1918, 2007.
64. Patel KP, Mayhan WG, Bidasee KR, and Zheng H. Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion. Am J Physiol Regul Integr Comp Physiol 300: R311-R320, 2011.
65. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JS, Sharma RV, and Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension 54: 1106-1114, 2009.
66. Phillips MI and Sumners C. Angiotensin II in central nervous system physiology. Regul Pept 78: 1-11, 1998.
67. Piccirillo G, Nocco M, Moise A, Lionetti M, Naso C, di Carlo S, and Marigliano V. Influence of vitamin C on baroreflex sensitivity in chronic heart failure. Hypertension 41: 1240-1245, 2003.
68. Puddu P, Puddu GM, Cravero E, De Pascalis S, and Muscari A. The putative role of mitochondrial dysfunction in hypertension. Clin Exp Hypertens 29: 427-434, 2007.
69. Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, and Labandeira-Garcia JL. Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease. Age (Dordr) 2011 [Epub ahead of print]; DOI: 10.1007/s11357-011-9284-7.
70. Rodriguez-Pallares J, Rey P, Parga JA, Muñoz A, Guerra MJ, and Labandeira-Garcia JL. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31: 58-73, 2008.
71. Rosenbaugh EG, Roat JW, Gao L, Yang RF, Manickam DS, Yin JX, Schultz HD, Bronich TK, Batrakova EV, Kabanov AV, Zucker IH, and Zimmerman MC. The attenuation of central angiotensin II-dependent pressor response and intra- neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials 31: 5218-5226, 2010.
72. Serrats J, Schiltz JC, Garcia-Bueno B, Rooijen NV, Reyes TM, and Sawchenko PE. Dual roles of perivascular macrophages in immune-to-brain signaling. Neuron 65: 94-106, 2010.
73. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C, and Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension 56: 297-303, 2010.
74. Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, Wang W, and Zhu GQ. Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Arch 458: 247-257, 2009.
75. Sirker A, Zhang M, and Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106: 735-747, 2011.
76. Skultetyova D, Filipova S, Riecansky I, and Skultety J. The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction. Recent Pat Cardiovasc Drug Discov 2: 23-27, 2007.
77. Sumbalová Z, Kucharská J, and Kristek F. Losartan improved respiratory function and coenzyme Q content in brain mitochondria of young spontaneously hypertensive rats. Cell Mol Neurobiol 30: 751-758, 2010.
78. Sun C, Sellers KW, Sumners C, and Raizada MK. NADPH oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96: 659-666, 2005.
79. Sun C, Sumners C, and Raizada MK. Chronotropic action of angiotensin II in neurons via protein kinase C and CaMKII. Hypertension 39: 562-566, 2002.
80. Sun C, Zubcevic J, Polson JW, Potts JT, Diez-Freire C, Zhang Q, Paton JF, and Raizada MK. Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat. Circ Res 105: 1248-1255, 2009.
81. Tai MH, Wang LL, Wu KLH, and Chan JYH. Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Radic Biol Med 38: 450-462, 2005.
82. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 7: 1302-1314, 2005.
83. Tsujimoto I, Hikoso S, Yamaguchi O, Kashiwase K, Nakai A, Takeda T, Watanabe T, Taniike M, Matsumura Y, Nishida K, Hori M, Kogo M, and Otsu K. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 45: 921-926, 2005.
84. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17: 3-8, 1997.
85. Veerasingham SJ, Yamazato M, Berecek KH, Wyss JM, and Raizada MK. Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat. Circ Res 96: 277-279, 2005.
86. Wang G, Anrather J, Glass MJ, Tarsitano MJ, Zhou P, Frys KA, Pickel VM, and Iadecola C. Nox2, Ca2 + , and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48: 482-489, 2006.
87. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, and Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004.
88. Wei SG, Yu Y, Zhang ZH, and Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296: H1425-H1433, 2009.
89. Wei SG, Yu Y, Zhang ZH, Weiss RM, and Felder RB. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension 52: 342-350, 2008.
90. Wei SG, Yu Y, Zhang ZH, Weiss RM, and Felder RB. Mitogen- activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52: 679-686, 2008.
91. Wei SG, Zhang ZH, Yu Y, and Felder RB. Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats. J Hypertens 27: 543-550, 2009.
92. Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, and Bauersachs J. Attenuation of angiotensin IIinduced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54: 338-344, 2009.
93. Wong SL, Lau CW, Wong WT, Xu A, Au CL, Ng CF, Ng SS, Gollasch M, Yao X, and Huang Y. Pivotal role of protein kinase Cd in angiotensin II-induced endothelial cyclooxygenase- 2 expression: a link to vascular inflammation. Arterioscler Thromb Vasc Biol 31: 1169-1176, 2011.
94. Xue B, Zhao Y, Johnson AK, and Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H1025-H1032, 2008.
95. Yi X, Zimmerman MC, Yang R, Tong J, Vinogradov S, and Kabanov AV. Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radic Biol Med 49: 548-558, 2010.
96. Yin JX, Yang RF, LI S, Renshaw AO, Li YL, Schultz HD, and Zimmerman MC. Mitochondrial-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current. Am J Physiol Cell Physiol 298: C857-C865, 2010.
97. Yu Y, Kang YM, Zhang ZH, Wei SG, Chu Y, Weiss RM, and Felder RB. Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor jB. Hypertension 49: 511-518, 2007.
98. Yu Y, Zhang ZH, Wei SG, Serrats J, Weiss RM, and Felder RB. Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension 55: 652-659, 2010.
99. Zadák Z, Hyspler R, Tichá A, Hronek M, Fikrová P, Rathouská J, Hrnciariková D, and Stetina R. Antioxidants and vitamins in clinical conditions. Physiol Res 58: 13-17, 2009.
100. Zalba G, Fortuño A, San José G, Moreno MU, Beloqui O, and Díez J. Oxidative stress, endothelial dysfunction and cerebrovascular disease. Cerebrovasc Dis 24: 24-29, 2007.
101. Zhang GX, Lu XM, Kimura S, and Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 76: 204-212, 2007.
102. Zhang M, Mao Y, Ramirez SH, Tuma RF, and Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171: 852-858, 2010.
103. Zhang ZH, Yu Y, Wei SG, and Felder FB. Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidase-dependent mitogen-activated protein kinase signaling. J Hypertens 28: 806-846, 2010.
104. Zimmerman MC. Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Curr Opin Pharmacol 11: 138-143, 2011.
105. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, and Davisson RL. Requirement for rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539, 2004.
106. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, and Davission RL. Superoxide mediates the action of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
107. Zimmerman MC, Sharma RV, and Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.
108. Zucker IH, Schultz HD, Patel KP, Wang W, and Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 297: H1557-H1566, 2009.